SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017751
Filing Date
2022-11-14
Accepted
2022-11-14 16:07:54
Documents
131
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aytu-20220930x10q.htm   iXBRL 10-Q 1760604
2 EX-31.1 aytu-20220930xex31d1.htm EX-31.1 15236
3 EX-31.2 aytu-20220930xex31d2.htm EX-31.2 14036
4 EX-32.1 aytu-20220930xex32d1.htm EX-32.1 14773
5 GRAPHIC aytu-20220930x10q001.jpg GRAPHIC 3651
  Complete submission text file 0001558370-22-017751.txt   10933387

Data Files

Seq Description Document Type Size
6 EX-101.SCH aytu-20220930.xsd EX-101.SCH 105496
7 EX-101.CAL aytu-20220930_cal.xml EX-101.CAL 83984
8 EX-101.DEF aytu-20220930_def.xml EX-101.DEF 364771
9 EX-101.LAB aytu-20220930_lab.xml EX-101.LAB 746108
10 EX-101.PRE aytu-20220930_pre.xml EX-101.PRE 660412
125 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20220930x10q_htm.xml XML 2172244
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38247 | Film No.: 221385188
SIC: 2834 Pharmaceutical Preparations